Lexpos News

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Clomethiazole 192mg capsules MSN/2024/067 Tier 2 – medium impact Date of issue: 5th June 2024 Clomethiazole 192mg capsules are out of stock until mid-June 2024 Clomethiazole 31.5mg/ml oral solution sugar free is currently out of stock until mid-July 2024 Alternative hypnotics/anxiolytics [...]

The post Medicine Supply Notification: Clomethiazole 192mg capsules appeared first on Community Pharmacy England.

Class 3 Medicines Recall: Atomoxetine 10mg, 18mg, 25mg, 40mg Capsules (Neuraxpharm UK Ltd) Drug alert number: EL (24)A/19 Date issued: 5 June 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 3 medicines recall for: Atomoxetine 10mg, 18mg, 25mg, 40mg Capsules (Neuraxpharm UK Ltd) Company name: Neuraxpharm UK Ltd Product name: Atomoxetine [...]

The post MHRA Class 3 Medicines Recall: Atomoxetine 10mg, 18mg, 25mg, 40mg Capsules (Neuraxpharm UK Ltd) appeared first on Community Pharmacy England.

GP Connect: Update Record is a new feature that CPCF IT system suppliers are adding to their systems, with Cegedim and Positive Solutions already live. Update Record allows information about patient consultations outside of general practice to be shared safely with general practice, so the information can be updated in the patient record. The messages [...]

The post Reminder: GP Connect: Update Record rollout appeared first on Community Pharmacy England.

We have issued the following clarification on the 2024/25 Community Pharmacy Contractual Framework (CPCF) negotiations. Our Chief Executive Janet Morrison said: “Government purdah effectively began as soon as the Prime Minister announced the General Election. Whilst discussions can continue no formal agreement can be reached until after the election and new Ministers are appointed. Current [...]

The post CPCF negotiations during the election period appeared first on Community Pharmacy England.

Following representations from Community Pharmacy England, the Department of Health of Social Care (DHSC) has re-determined the special container status of Drospirenone (Slynd®) 4mg tablets. From 1 June 2024, Drospirenone (Slynd®) 4mg tablets were re-classified as a special container at sub-pack level (sub-pack of 28) as they meet the relevant criteria as set out in Part II [...]

The post Drospirenone (Slynd®) 4mg tablets re-classified as a special container appeared first on Community Pharmacy England.